The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia.
Ma Y, Zhou H, Zhang J, Zhang Q, Li Y, Xie R, Zhang B, Shen Z, Li P, Liang A, Zhou K, Han L, Hu Y, Xu K, Sang W, Wang X.
Ma Y, et al. Among authors: zhang b, zhang q, zhang j.
Front Immunol. 2024 Sep 27;15:1448709. doi: 10.3389/fimmu.2024.1448709. eCollection 2024.
Front Immunol. 2024.
PMID: 39399502
Free PMC article.